Flow For the year 2017, the Company has increasing in net cash and cash equivalents totaling Baht 79.98 million when compare with previous year. The details of cash flows each activities as follows

continually encourages the use of B20; for instance, supporting the consumption of B20 in public buses and other public transportations, by increasing price subsidies on B20 to be cheaper than B7 at 5 Baht

, net loss came from low sale volume which affected from the increasing of import volume from foreign country in May and June 2019. Business Outlook Post termination of Tolling Activities in January, 2019

hemodialysis Center in Bangkok and two hemodialysis Center in northeastern provinces, where patients are continuously increasing. Now, the company continue to focus on expanding hemodialysis Center. Medical

3Q2018, decreased by THB 89.36 million or 11.24% down from 3Q2017 affected by increasing in cost of sales. The consolidated gross profit margin contributed of 15.63% in 3Q2018, decreased from 18.08% in

COVID-19 situation and the increasing of incoming tourists due to the relaxation of government measures against COVID-19, as a result more customers are eating-out and having desserts. • Revenue from Non

last year, with the 9M/2023 average funding cost 2.97%, increasing from 2.64% at the end of last year, due to the announcement of the Monetary Policy Committee (MPC) to increase the policy interest rate

%, increasing from 2.64% at the end of last year, due to the announcement of the Monetary Policy Committee (MPC) to increase the policy interest rate from 0.50% in 2022 to 2.50 as of November 2023 and the rate

of foreign exchange, deferred income tax, impairment and lease income for the year 2018 were Baht 23,372 million, increasing by Baht 14,104 million comparing to 2017, which came from a increase in

28.6% when compared to the third quarter of 2017. Almost of net non-interest income are dividend income, which came from increasing investments - net by 2.6%. Other Operating Expenses In the third